Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Sperm Selection by Microfluidic Separation Improves Embryo Quality

NCT03085433 · View on ClinicalTrials.gov ↗

Study Summary

This is a randomized controlled trial of couples with a history of poor embryo quality undergoing a repeat in vitro fertilization (IVF) cycle for unexplained infertility. Couples will be randomized to sperm selection by the clinical standard of centrifugation and density-gradient processing compared to the microfluidic sperm sorting chip.

Interventions

  • DEVICE Microfluidic Sperm Sorting
  • PROCEDURE in vitro fertilization

Study Locations (1)

California

  • University of California San Francisco — San Francisco

Trial Details

FieldValue
Enrollment Target 393 participants
Start Date 2017-06-20
Est. Completion 2022-04-30
Phase NA

Sponsor

University of California, San Francis

1,574 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03085433

The ClinicalTrials.gov registry entry for NCT03085433 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 393 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francis, which has 1,574 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 6 conditions, with Infertility appearing as the primary indexed condition, and to 2 interventions — of which Microfluidic Sperm Sorting is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT03085433 reports 1 study location spanning 1 distinct geographic area — top geographies include California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT03085433 about?

NCT03085433 is a clinical study titled "Sperm Selection by Microfluidic Separation Improves Embryo Quality". This is a randomized controlled trial of couples with a history of poor embryo quality undergoing a repeat in vitro fertilization (IVF) cycle for unexplained infertility. Couples will be randomized to sperm selection by the clinical standard of centrifugation and density-gradient processing compared...

What is the current status of trial NCT03085433?

This trial is currently completed. It is a NA study. The enrollment target is 393 participants. The study started on 2017-06-20. Estimated completion is 2022-04-30.

What conditions does trial NCT03085433 study?

This clinical trial studies the following conditions: Infertility, Infertility, Male, Fertility Disorders, Sperm DNA Fragmentation, Infertility Unexplained. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT03085433?

The interventions under investigation include: Microfluidic Sperm Sorting (DEVICE), in vitro fertilization (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT03085433?

This trial is sponsored by University of California, San Francis, which has 1,574 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT03085433 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial